Monkey Anti-HIV-1 gp120 Recombinant Antibody (clone 2.5B) (CAT#: PABL-530)

Recombinant Monkey Antibody (mAb2.5B) is capable of binding to HIV-1 gp120, expressed in mammalian cells.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Published Data
  • Datasheet
  • MSDS
  • COA
Inhib

Figure 1 Competing the capturing of virions by RhMAbs with human MAbs.

Figure 1 Competing the capturing of virions by RhMAbs with human MAbs.

SF162 virions were first incubated with the human anti-HIV-1 Env MAbs 447 (anti-V3), 830A (anti-V2), 2909 (anti-quaternary epitope), 860-55 (anti-parvovirus, used as a negative internal control), or soluble CD4 and then added to wells coated with the indicated MAbs (x axis). Inhibition of capturing is represented as the percent reduction in virion capturing (y axis) compared to the capturing of SF162 virions that were not preincubated with human MAbs or sCD4.

Robinson, J. E., Franco, K., Elliott, D. H., Maher, M. J., Reyna, A., Montefiori, D. C., ... & Stamatatos, L. (2010). Quaternary epitope specificities of anti-HIV-1 neutralizing antibodies generated in rhesus macaques infected by the simian/human immunodeficiency virus SHIVSF162P4. Journal of virology, 84(7), 3443-3453.

Neut

Figure 2 Role of the KV dipeptide in V2 on MAb neutralizing activities.

Figure 2 Role of the KV dipeptide in V2 on MAb neutralizing activities.

The lysine at position 158 (position 160, based on the HxB2 numbering) in the V2 loop of the SF162 Env was altered to alanine (V159A). The neutralizing susceptibilities of the corresponding mutant viruses to the RhMAbs 2.2G, 2.3E, 2.5B, and the human MAb 2909 were determined.

Robinson, J. E., Franco, K., Elliott, D. H., Maher, M. J., Reyna, A., Montefiori, D. C., ... & Stamatatos, L. (2010). Quaternary epitope specificities of anti-HIV-1 neutralizing antibodies generated in rhesus macaques infected by the simian/human immunodeficiency virus SHIVSF162P4. Journal of virology, 84(7), 3443-3453.

Neut

Figure 3 Effect of V2 loop NLGSs on the neutralizing activity of RhMAbs and MAb 2909.

Figure 3 Effect of V2 loop NLGSs on the neutralizing activity of RhMAbs and MAb 2909.

The V2 glycosylation sites (154, 186, and 195) were eliminated from the SF162 Env by mutating either the asparagines to glutamines or the serines to alanines. The amino acid sequence of the SF162. V2 loop is shown (numbering is based on SF162). The N-linked glycosylation sites are underlined.

Robinson, J. E., Franco, K., Elliott, D. H., Maher, M. J., Reyna, A., Montefiori, D. C., ... & Stamatatos, L. (2010). Quaternary epitope specificities of anti-HIV-1 neutralizing antibodies generated in rhesus macaques infected by the simian/human immunodeficiency virus SHIVSF162P4. Journal of virology, 84(7), 3443-3453.


Specifications

  • Host Species
  • Monkey
  • Type
  • Monkey IgG1, λ
  • Specificity
  • Tested positive against HIV-1 gp120
  • Species Reactivity
  • HIV-1
  • Clone
  • 2.5B
  • Applications
  • Inhib, Neut

Product Property

  • Purity
  • >95% as determined by SDS-PAGE
  • Concentration
  • Please refer to the vial label for the specific concentration.
  • Buffer
  • PBS
  • Preservative
  • No preservatives
  • Storage
  • Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Applications

  • Application Notes
  • This antibody has been reported for use in Neutralization and Inhibition Assay.

Target

  • Alternative Names
  • ENV; gp160; envelope glycoprotein; Envelope surface glycoprotein gp160, precursor; hypothetical protein; Envelope surface glycoprotein gp120; Envelope transmembrane domain

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone 2.5B"

See other products for "HIV-1 gp120"

Single-domain Antibody

Chimeric Antibody

CAT Product Name Application Type
MRO-135LC Anti-HIV-1 gp120 Recombinant Antibody (CAG1-51-4) ELISA, WB, Neut Chimeric antibody (mouse/human)
MRO-135LC-S(P) Anti-HIV-1 gp120 Recombinant Antibody scFv Fragment (CAG1-51-4) ELISA, WB Chimeric antibody (mouse/human)
MRO-135LC-F(E) Anti-HIV-1 gp120 Recombinant Antibody Fab Fragment (CAG1-51-4) ELISA, WB Chimeric antibody (mouse/human)

Rabbit Monoclonal Antibody

CAT Product Name Application Type
MOR-4220 Rabbit Anti-HIV-1 gp120 Recombinant Antibody (clone SI299DS) WB, ELISA Rabbit IgG

Humanized Antibody

CAT Product Name Application Type
PABX-101-S(P) Human Anti-HIV-1 gp120 Recombinant Antibody (clone PG9); scFv Fragment WB, ELISA, FuncS Human scFv

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for PABL-530. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare